Przejdź do zawartości
Merck

Modulatory effects of extracts of vinegar-baked Radix Bupleuri and saikosaponins on the activity of cytochrome P450 enzymes in vitro.

Xenobiotica; the fate of foreign compounds in biological systems (2014-05-02)
Tongya Yu, Xianzhi Chen, Yinjie Wang, Ruizhi Zhao, Shirui Mao
ABSTRAKT

1. In this article, the modulatory effects of extracts from vinegar-baked Radix Bupleuri (VBRB) and saikosaponins on the activity of CYP1A2, CYP2C9 and CYP3A4 were investigated in vitro. 2. Microsomal in vitro incubation method was utilized to simulate metabolic reaction under physiological environment by incubating the marker with liver microsomes in the absence or presence of VBRB and saikosaponins. The contents of 4-acetamidophenol, 6β-hydroxyltestosterone and 4-hydroxydiclofenac, the metabolites of phenacetin, testosterone and diclofenac, which were selected as specific probe drugs of CYP1A2, CYP2C9 and CYP3A4, respectively, were analyzed by high-performance liquid chromatography. 3. The production of the metabolites was incubation time dependent. The modulatory effects of different VBRB extracts and saikosaponins on CYP isoforms increased with concentration. Among all the extracts studied, BC1 has a strong inhibition effect compared to the three CYP isoforms tested, while the others have only significant inhibition on the activity of CYP2C9. 4. This in vitro study demonstrated that various extracts of VBRB tested in this study have negligible potential to interfere with CYP1A2- and CYP3A4-metabolized drugs; risk of herb-drug interaction might occur when VBRB is concurrently taken with CYP2C9 substrates.

MATERIAŁY
Numer produktu
Marka
Opis produktu

Paracetamol, European Pharmacopoeia (EP) Reference Standard
Supelco
Diclofenac sodium salt, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Testosterone, purum, ≥99.0% (HPLC)
Sigma-Aldrich
Diclofenac sodium salt
Supelco
Phenacetin, Pharmaceutical Secondary Standard; Certified Reference Material
USP
Standardowa temperatura topnienia fenacetyny, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Phenacetin, ≥98.0% (HPLC)
Supelco
Testosterone, VETRANAL®, analytical standard
Supelco
Testosterone solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®
Supelco
Phenacetin melting point standard, Pharmaceutical Secondary Standard; Certified Reference Material
Testosterone, European Pharmacopoeia (EP) Reference Standard
Supelco
Diclofenac sodium salt, analytical standard
Diclofenac for system suitability, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
β-Nicotinamide adenine dinucleotide phosphate sodium salt, pkg of 5 mg (per vial)
Sigma-Aldrich
β-Nicotinamide adenine dinucleotide phosphate sodium salt, pkg of 10 mg (per vial)
Supelco
Acetaminophen, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Acetaminophen, BioXtra, ≥99.0%
Sigma-Aldrich
Acetaminophen, analytical standard
Sigma-Aldrich
β-Nicotinamide adenine dinucleotide phosphate hydrate
Sigma-Aldrich
Acetaminophen, meets USP testing specifications, 98.0-102.0%, powder
Diclofenac sodium, European Pharmacopoeia (EP) Reference Standard
Supelco
Acetaminophen solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
USP
Diklofenak sodowy, United States Pharmacopeia (USP) Reference Standard
USP
Acetaminofen, United States Pharmacopeia (USP) Reference Standard